View all data FOR FREE!
Create an account today, no credit card required.
| Issue Type | XXXX |
|---|---|
| Country | United States |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2043-04-15 |
| Par Value | 2000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 639.07 |
| Coupon | 0 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 639.074 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Abbott Laboratories corporate note has a N/A fixed rate coupon paid on a semi-annual basis. It was issued on March 22, 2017 with an issue size of 639.07 million USD and matures on April 15, 2043 with a last coupon date of October 15, 2042. |
Abbott Laboratories, founded in 1888 and headquartered in Abbott Park, Illinois, is a global healthcare company dedicated to advancing health through the development of innovative products and technologies. The company operates in several segments, including nutrition, diagnostics, medical devices, and pharmaceuticals, offering a wide range of products such as baby formula, blood glucose monitoring systems, and cardiac devices.